Overview
Histapharma develops medicinal products for respiratory and allergic diseases, including asthma, COPD, allergic rhinitis, skin allergies and chronic urticaria. The company invites partners to cooperate through product licensing or by supplying finished products for further distribution.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 49 days early.
- 202515/05/2026
- 202423/05/2025
- 202301/07/2024
- 202214/06/2023
- 202122/06/2022
- 202024/06/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
- Manufacture of other chemical products (20.5)
- Manufacture of basic pharmaceutical products (21.1)
Authorized Representatives
Manner of representation
In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 196 | $2,647.22 | 49% | |
Katarzyna Joanna Nagórkoage 51 | 100 | $1,350.62 | 25% |
Andrzej Ostrowiczage 70 | 104 | $1,404.65 | 26% |
Beneficial owners
| Person | Rights |
|---|---|
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Apr 27, 2018 | Aid for SME access to finance — aid for start-ups | $376.4K$376,377 | Dyrektor Narodowego Centrum Badań i Rozwoju |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| F1 PharmaS.A. | $272,113.66 | f1pharma.pl | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| N - Symbiosis Polskasp. z o.o. | $121,129.36 | n-symbiosis.com | ||
| Bioresearch PharmaS.A. | $76,294.71 | bioresearchpharma.com | ||
| Meta Pharmaceutical Productionsp. z o.o. | $41,273.73 | metapharmaceutical.pl | ||
| Amorphis Pharma Developmentsp. z o.o. | $35,766.66 | amorphispharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2018-06-27 | Address change (1, 62-002, Złotniki → Ul. Krzemowa 1, 62-002, Złotniki) | |
| 2018-06-27 | Share capital increase (5,000.00 PLN → 20,000.00 PLN) | |
| 2018-04-25 | Entered in the register |
FAQ
Last updated: 2026-07-14